PWSG
BMY icon

Pacific Wealth Strategies Group’s Bristol-Myers Squibb BMY Stock Holding History

Pacific Wealth Strategies Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,088
Closed -$1.61M – 48
2022
Q1 		$1.61M Buy
22,088
+24
+0.1% +$1.61K 0.68% 34
2021
Q4 		$1.38M Buy
22,064
+3,035
+16% +$178K 0.48% 46
2021
Q3 		$1.13M Buy
19,029
+758
+4% +$49.9K 0.42% 50
2021
Q2 		$1.22M Hold
18,271
– – 0.47% 50
2021
Q1 		$1.15M Sell
18,271
-721
-4% -$44.9K 0.48% 53
2020
Q4 		$1.19M Sell
18,992
-91
-0.5% -$5.6K 0.51% 48
2020
Q3 		$1.15M Sell
19,083
-627
-3% -$37.7K 0.6% 44
2020
Q2 		$1.16M Buy
19,710
+471
+2% +$28.2K 0.64% 43
2020
Q1 		$1.07M Buy
19,239
+42
+0.2% +$2.57K 0.73% 44
2019
Q4 		$1.23M Buy
19,197
+232
+1% +$13.3K 0.68% 49
2019
Q3 		$962K Buy
18,965
+2,565
+16% +$121K 0.59% 55
2019
Q2 		$744K Buy
16,400
+797
+5% +$37.1K 0.47% 62
2019
Q1 		$744K Buy
15,603
+392
+3% +$19.5K 0.48% 62
2018
Q4 		$791K Buy
15,211
+129
+0.9% +$6.93K 0.57% 57
2018
Q3 		$936K Sell
15,082
-67
-0.4% -$3.98K 0.6% 56
2018
Q2 		$838K Sell
15,149
-42
-0.3% -$2.27K 0.58% 54
2018
Q1 		$961K Buy
15,191
+271
+2% +$17.4K 0.68% 52
2017
Q4 		$914K Buy
14,920
+144
+1% +$9.01K 0.65% 53
2017
Q3 		$942K Buy
14,776
+1,271
+9% +$74.2K 0.74% 47
2017
Q2 		$752K Buy
13,505
+4,466
+49% +$243K 0.64% 50
2017
Q1 		$492K Buy
9,039
+1,511
+20% +$82.9K 0.43% 57
2016
Q4 		$440K Buy
+7,528
New +$412K 0.43% 52

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Pacific Wealth Strategies Group's BMY Position: Q2 2022 in Review

Pacific Wealth Strategies Group sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 22,088 shares — an estimated $1.61M sold.

Pacific Wealth Strategies Group first reported a position in BMY in Q4 2016 and held it in 22 quarters. The position peaked at $1.61M in Q1 2022. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

  • Pacific Wealth Strategies Group reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
  • Pacific Wealth Strategies Group sold 22,088 Bristol-Myers Squibb shares in Q2 2022, an estimated $1.61M.
  • Pacific Wealth Strategies Group first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 22 quarters.
  • Pacific Wealth Strategies Group's Bristol-Myers Squibb position peaked at $1.61M in Q1 2022.
  • 2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Pacific Wealth Strategies Group's 13F filing for Q2 2022, filed 19 Jul 2022.